Tilray | TRLY - Current Liabilities

Stock Price
10.64
Daily Change
-0.16 -1.48%
Monthly
-10.89%
Yearly
688.15%
Q1 Forecast
10.37

Tilray reported $280.3M in Current Liabilities for its fiscal quarter ending in March of 2025.





Current Liabilities Change Date
Acasti Pharma USD 1.24M 1.08M Sep/2025
Akebia Therapeutics USD 133.38M 14.66M Sep/2025
Alaunos Therapeutics USD 921K 153K Sep/2025
Aurora Cannabis CAD 124.12M 32.76M Sep/2025
Avita Medical AUD 62.6M 42.44M Jun/2025
Canopy Growth CAD 81.1M 17.56M Sep/2025
Cronos Group USD 41.07M 3.45M Sep/2025
Dianthus Therapeutics USD 23.86M 3.76M Sep/2025
Divis Laboratories Ltd INR 17.28B 2.76B Sep/2025
Ionis Pharmaceuticals USD 903.46M 6.22M Sep/2025
IQVIA Holdings USD 8.34B 170M Dec/2025
Knight Therapeutics CAD 118.15M 12.32M Sep/2024
Moderna USD 1.99B 306M Dec/2025
Organigram Holdings CAD 126.16M 18.88M Sep/2025
Organon & Co USD 2.68B 117M Sep/2025
Revvity USD 1.33B 108.5M Dec/2025
Tectonic Therapeutic USD 9.37M 1.99M Sep/2025
Tilray USD 280.3M 18.13M Mar/2025
Viatris USD 7.36B 230.7M Sep/2025
Xeris Pharmaceuticals USD 116.2M 21.03M Sep/2025